Status:
UNKNOWN
Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children
Lead Sponsor:
NasVax Ltd
Conditions:
Acute Otitis Media
Eligibility:
All Genders
3-3 years
Brief Summary
This clinical study is designed to assess prospectively the sero-responses to various proteins in cases of pneumococcal Acute Otitis Media.
Eligibility Criteria
Inclusion
- Male and female Jewish and Bedouin children.
- Patients can be either ambulatory or hospitalized.
- Presenting with acute otitis media.
- Tympanocentesis was performed at least in one ear for a clinical indication.
- Culture of middle ear fluid was obtained.
- Parents agreeing to participate in the study and to submit their children for follow-up, blood test and nasopharyngeal/oropharyngeal (NP/OP) cultures.
Exclusion
- Having another infection that is likely to be caused by S. pneumoniae.
- Known immunodeficiency.
- Known previous recent pneumococcal infections (\<1 month prior to current visit).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01214538
Start Date
October 1 2010
End Date
July 1 2014
Last Update
September 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ben-Gurion University of the Negev
Beersheba, Israel, 84101